DECCAN
HEALTHCARE LIMITED BSE SME IPO TO OPEN
ON DECEMBER 18, 2018
WITH PRICE BAND OF
RS. 95 TO RS. 100 PER EQUITY SHARE OF FACE VALUE OF RS. 10 EACH
· THE INITIAL PUBLIC OFFERING OF 42,12,000EQUITY
SHARES AGGREGATING RS. 42.12 CRORES (AT CAP PRICE)
· THE IPO CONSISTS OF FRESH ISSUE OF 22,12,000EQUITY
SHARES AGGREGATING RS. 22.12 CRORES (AT CAP PRICE)
· THE IPO CONSISTS OF OFFER FOR SALE OF
20,00,000 EQUITY SHARES AGGREGATING RS. 20.00 CRORES (AT CAP PRICE)
· THE MINIMUM BID LOT IS 1,200 EQUITY SHARES
AND IN MULTIPLES OF 1,200 EQUITY SHARES THEREAFTER.
·
OFFER
OPENING DATE – DECEMBER 18, 2018 AND OFFER CLOSING DATE – DECEMBER 20, 2018
Deccan
Health Care Limited, engaged in the
business ofdeveloping, manufacturing and marketing a broad range of healthcare
products including nutraceutical, cosmeceutical and ayurveda products,will be
launching its BSE SME initial public offering (“IPO” or the “Issue”), which is scheduled to open on December 18,
2018 and close on December 20, 2018, with a price
band of Rs. 95 to Rs. 100 per Equity Share of face value of Rs. 10 each of the
Company (the “Equity Shares”).
The
Initial Public Offering of 42,12,000 Equity Shares of face value of 10/-each aggregating
to Rs 4,212.00* lakhs (“offer”) comprising a fresh issue of 22,12,000 equity
shares aggregating to Rs. 2,212.00* lakhs by the company (“fresh issue”) and an
offer for sale of 14,00,000 equity shares by Hitesh Patel (referred to as the “
promoter selling shareholder) and 6,00,000 equity shares by Meenakshi Gupta (referred
to as the “selling shareholder”) aggregating 20,00,000 equity shares by the
selling shareholders (“offer for sale”) and together with the fresh issue (“the
offer”).
The
offer comprises of 2,11,200equity shares of face value Rs. 10/- aggregating Rs.
211.20*lakhs which will be reserved for subscription by the market maker to the
offer (the “market maker reservation portion”).
The
offer less market maker reservation portion i.e. offer of 40,00,800equity shares
of face value of Rs. 10/- each, aggregating Rs. 4,000.80* Lakhs is hereinafter
refer to as the “net offer”. The offer and the net offer will constitute 26.81
% and 25.46 %, respectively of the fully diluted post offer paid up equity
share capital of our company.
The
face value of the equity shares is Rs 10 each.The Net Proceeds will be utilized
for Repayment/Prepayment of certain Secured Borrowings availed by the Company,
Purchase of Plant & Machinery and related civil work andGeneral Corporate
Purposes.
In
terms of SEBI Circular No. CIR/CFD/POLICYCELL/11/2015, all potential investors
shall participate in the Offer only through an Application Supported by
BlockedAmount (“ASBA”) process providing details about the bank account which
will be blocked by the Self Certified Syndicate Banks (“SCSBs”) for the same.
Pantomath Capital Advisors Private
Limitedis the Book Running Lead Manager to the issue and Bigshare Services Private Ltd is the
Registrar to the Issue. The Equity Shares of Deccan Health Care Limitedare proposed to be
listed on SME Platform of BSE Limited.
*Calculated on the cap price
ABOUT
DECCAN HEALTHCARE LIMITED
Hyderabad
based Deccan Health Care Limited, Incorporated in the year 1996, is into
developing, manufacturing and marketing a broad range of healthcare products
including nutraceutical, cosmeceutical and ayurveda products. The company with
an operating history of more than two decades aims to distinguish identity by
focusing on ways to bridge the nutrition gap which is a recognised cause of
many diseases.The company has identified over 50 consumer wellness goals and
over 200 diseases, disorders disabilities which can be prevented by meeting RDA
of micronutrients.
The
company has innovated and developed cost effective products that are unique and
differentiated to combat such diseases. In 2010, the company set up own
manufacturing facility at SIDCUL Pantnagar Rudrapur, Uttarakhand. The company
has a diversified product portfolio with product basket consisting of more than
1,500 products used for various purposes such as hair care, skin care, heart
care, immunity building, etc. We have the ability to supply products in various
forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc.
The
Company is also an ISO 9001:2015 certified for Quality management System for
manufacturing and supply of Nutraceutical & Pharmaceutical Products. Spread
over 3,536 Sq. mts., its manufacturing facility is equipped with the requisite
plant and machineries including Effluent Treatment Plant and other resources
required for our manufacturing process. The company posted annual turnover of Rs.
3,976.07 lakhs in 2018 from Rs. 1,617.70 lakhs in the year 2016.
No comments:
Post a Comment